GlaxosmithKline Plc reports profit after tax of N62.79 million in Q3 2021

GlaxoSmithKline Plc released its unaudited financial results for the third quarter of the year ended 30th of September, 2021. 

  • Revenue during the period was N6.59 billion. (+9.55% YoY)  
  • Cost of sales stood at N4.99 billion. (+11.10% YoY) 
  • Selling and Distribution costs for the period was N1.15 billion. (+20.21% YoY) 
  • Administrative expenses of N559 million was recorded. 
  • Profit before tax was N92.64 million (+49.88%). Total assets during the period stood at N23.49 billion. (+1.23 bn YoY) 
  • Profit after tax was N62.79 million. (+49.41 YoY) 
  • Earnings per share of 5 kobo Vs 4 kobo YoY. 

See link to results